Sphera Funds Management LTD Has Raised Its Position in Biomarin Pharmaceutical (BMRN) by $930,000; Breton Hill Capital LTD Cut Its Sanderson Farms (SAFM) Stake by $415,702

February 15, 2018 - By David Stenberg

Ray Carroll decreased its stake in Sanderson Farms Inc (SAFM) by 16.59% based on its latest 2017Q3 regulatory filing with the SEC. Breton Hill Capital Ltd sold 2,582 shares as the company’s stock rose 21.33% with the market. The hedge fund run by Ray Carroll held 12,977 shares of the consumer non-durables company at the end of 2017Q3, valued at $2.10 million, down from 15,559 at the end of the previous reported quarter. Breton Hill Capital Ltd who had been investing in Sanderson Farms Inc for a number of months, seems to be less bullish one the $2.99 billion market cap company. The stock increased 2.72% or $3.47 during the last trading session, reaching $131.16. About 312,017 shares traded. Sanderson Farms, Inc. (NASDAQ:SAFM) has risen 33.01% since February 15, 2017 and is uptrending. It has outperformed by 16.31% the S&P500.

Sphera Funds Management Ltd increased its stake in Biomarin Pharmaceutical Inc (BMRN) by 13.33% based on its latest 2017Q3 regulatory filing with the SEC. Sphera Funds Management Ltd bought 10,000 shares as the company’s stock declined 0.71% while stock markets rallied. The institutional investor held 85,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $7.91M, up from 75,000 at the end of the previous reported quarter. Sphera Funds Management Ltd who had been investing in Biomarin Pharmaceutical Inc for a number of months, seems to be bullish on the $14.85 billion market cap company. The stock increased 3.64% or $2.97 during the last trading session, reaching $84.54. About 1.44 million shares traded or 12.59% up from the average. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has risen 5.29% since February 15, 2017 and is uptrending. It has underperformed by 11.41% the S&P500.

Breton Hill Capital Ltd, which manages about $698.62 million and $542.23 million US Long portfolio, upped its stake in Ppl Corp (NYSE:PPL) by 58,479 shares to 303,756 shares, valued at $11.53 million in 2017Q3, according to the filing. It also increased its holding in Philip Morris Intl Inc (NYSE:PM) by 7,772 shares in the quarter, for a total of 111,770 shares, and has risen its stake in Pfizer Inc (NYSE:PFE).

Analysts await Sanderson Farms, Inc. (NASDAQ:SAFM) to report earnings on February, 22. They expect $1.21 earnings per share, up 18.63% or $0.19 from last year’s $1.02 per share. SAFM’s profit will be $27.62M for 27.10 P/E if the $1.21 EPS becomes a reality. After $3.20 actual earnings per share reported by Sanderson Farms, Inc. for the previous quarter, Wall Street now forecasts -62.19% negative EPS growth.

Investors sentiment decreased to 0.87 in Q3 2017. Its down 0.07, from 0.94 in 2017Q2. It is negative, as 45 investors sold SAFM shares while 98 reduced holdings. 62 funds opened positions while 63 raised stakes. 21.94 million shares or 0.56% less from 22.07 million shares in 2017Q2 were reported. Massachusetts-based Barry Investment Advsrs Llc has invested 0.1% in Sanderson Farms, Inc. (NASDAQ:SAFM). Dreman Value L L C, a Florida-based fund reported 2,987 shares. Voya Investment Mngmt Ltd Llc invested in 0% or 9,629 shares. National Bank Of Mellon Corp accumulated 282,624 shares. Advantus Mngmt has invested 0.01% in Sanderson Farms, Inc. (NASDAQ:SAFM). Dimensional Fund Advsr LP holds 1.48 million shares or 0.1% of its portfolio. Credit Agricole S A owns 0.01% invested in Sanderson Farms, Inc. (NASDAQ:SAFM) for 19,300 shares. 86,398 were accumulated by New York State Common Retirement Fund. Guggenheim Capital Limited Liability Corporation holds 0.03% of its portfolio in Sanderson Farms, Inc. (NASDAQ:SAFM) for 75,524 shares. Profund Advsrs Ltd Co stated it has 0.01% of its portfolio in Sanderson Farms, Inc. (NASDAQ:SAFM). Ftb Advsr Inc has 53 shares. France-based Cap Fund Mgmt Sa has invested 0.01% in Sanderson Farms, Inc. (NASDAQ:SAFM). Arizona State Retirement Systems reported 11,400 shares. Carroll Financial Associates owns 0% invested in Sanderson Farms, Inc. (NASDAQ:SAFM) for 225 shares. Blackrock invested 0.02% of its portfolio in Sanderson Farms, Inc. (NASDAQ:SAFM).

Among 14 analysts covering Sanderson Farms Inc. (NASDAQ:SAFM), 5 have Buy rating, 4 Sell and 5 Hold. Therefore 36% are positive. Sanderson Farms Inc. had 34 analyst reports since August 26, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Monday, October 2 by Mizuho. As per Monday, March 27, the company rating was upgraded by KeyBanc Capital Markets. BMO Capital Markets maintained Sanderson Farms, Inc. (NASDAQ:SAFM) on Friday, August 11 with “Hold” rating. The stock has “Market Perform” rating by BMO Capital Markets on Friday, August 25. The firm has “Hold” rating given on Thursday, October 12 by BMO Capital Markets. As per Thursday, December 3, the company rating was upgraded by Credit Agricole. Sidoti upgraded the stock to “Buy” rating in Monday, December 12 report. The firm has “Sell” rating given on Friday, October 6 by J.P. Morgan. BMO Capital Markets maintained Sanderson Farms, Inc. (NASDAQ:SAFM) on Thursday, November 16 with “Hold” rating. Jefferies initiated the stock with “Underperform” rating in Wednesday, December 16 report.

Since August 25, 2017, it had 0 insider purchases, and 5 insider sales for $1.09 million activity. 1,371 shares were sold by MOONEY DIANNE, worth $198,771. 1,775 shares were sold by KHAYAT ROBERT C, worth $252,593 on Tuesday, August 29. $86,269 worth of Sanderson Farms, Inc. (NASDAQ:SAFM) was sold by Bierbusse John. LIVINGSTON PHIL K sold 900 shares worth $123,714.

Among 27 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 21 have Buy rating, 0 Sell and 6 Hold. Therefore 78% are positive. BioMarin Pharmaceutical had 78 analyst reports since August 5, 2015 according to SRatingsIntel. Leerink Swann maintained the shares of BMRN in report on Tuesday, February 23 with “Outperform” rating. The firm has “Outperform” rating given on Thursday, December 14 by Wedbush. Barclays Capital maintained the stock with “Overweight” rating in Friday, February 26 report. Stifel Nicolaus maintained BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on Thursday, August 3 with “Buy” rating. The firm earned “Outperform” rating on Tuesday, March 22 by Credit Suisse. Oppenheimer maintained it with “Perform” rating and $99 target in Tuesday, February 23 report. The company was maintained on Wednesday, December 20 by Wedbush. The rating was upgraded by Stifel Nicolaus on Tuesday, February 16 to “Buy”. The firm earned “Buy” rating on Wednesday, October 18 by Stifel Nicolaus. Barclays Capital maintained BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) rating on Friday, August 5. Barclays Capital has “Overweight” rating and $125 target.

Sphera Funds Management Ltd, which manages about $700.90M US Long portfolio, decreased its stake in Array Biopharma Inc (NASDAQ:ARRY) by 295,000 shares to 405,000 shares, valued at $4.98M in 2017Q3, according to the filing. It also reduced its holding in Orbotech Ltd (NASDAQ:ORBK) by 38,497 shares in the quarter, leaving it with 175,243 shares, and cut its stake in Adamas Pharmaceuticals Inc (NASDAQ:ADMS).

Investors sentiment decreased to 1.13 in Q3 2017. Its down 0.13, from 1.26 in 2017Q2. It turned negative, as 40 investors sold BMRN shares while 116 reduced holdings. 45 funds opened positions while 132 raised stakes. 171.51 million shares or 2.04% more from 168.09 million shares in 2017Q2 were reported. Metropolitan Life reported 13,167 shares or 0.01% of all its holdings. Thomas J Herzfeld Advisors stated it has 400 shares. Employees Retirement Association Of Colorado invested in 0.02% or 33,065 shares. 200 were accumulated by Hanson & Doremus Invest Mgmt. Dynamic Cap Mngmt has invested 0.94% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Geode Cap Management Ltd Liability Co holds 0.05% or 1.43 million shares. Weiss Multi stated it has 70,000 shares. Eulav Asset Management has invested 0.46% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Gotham Asset Ltd Liability Corporation reported 3,590 shares or 0% of all its holdings. Point72 Asset Mgmt Limited Partnership reported 769,542 shares. Bb&T Corporation has invested 0.03% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). 258,061 are owned by Amf Pensionsforsakring Ab. Americafirst Cap Mgmt Ltd Llc accumulated 7,548 shares. 327,649 are held by Barclays Pcl. M&T Bankshares Corporation reported 13,580 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 David Stenberg

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts